Menu

From Little Things Big Things Grow

We should take comfort in the fact that life on Earth had such unassuming, shared beginnings.

Jun 1, 2018
Bob Grant

ANDRZEJ KRAUZEThere was a sign hanging on the door of a microbial ecology lab at the South Carolina Department of Natural Resources, where I did my marine biology master’s thesis work: “Respect bacteria—they’re the only culture some people have.”

This homage to our single-celled partners on this planet stuck with me over the years, and my appreciation of microbes has only grown as I’ve learned more and more about them—most recently, the central role archaea have played in the evolution of life on Earth.

The current thought is that millions of years ago, archaeal ancestors of eukaryotes and ancient bacterial species engaged in fortuitous (as least from the human perspective) acts of cellular hanky-panky. Engulfed by more-complex, nucleated cells, bacteria entered into a symbiotic relationship with their archaeal hosts, and the partnership blossomed.

Eventually, the symbionts evolved into a new type of cell, with those encapsulated bacteria morphing into mitochondria and chloroplasts, essential engines of the eukaryotic newcomers.

And how lucky we eukaryotes are to count archaea as distant evolutionary relations. Without them, eukaryotic cells might never have come about, and the most spectacular life forms—forests full of trees, shoals of giant fish, flocks of bright birds—might be missing from our planet.

As researchers prospect ever further for archaeal species, the ancient prokaryotes, which were initially misidentified as bacteria, are turning up virtually everywhere: in the alkaline lakes and hot springs where intrepid naturalists originally found them, but also in forest soils, marshlands, ocean waters, and even the human body. Scientists recently detected members of this ancient microbial group inhabiting human lungs, colons, mouths, and skin. So I guess some people have at least two cultures.

As befits a fascinating corner of biology, research on archaea continues to surprise. Not only are the organisms turning up in unexpected places, but from every new pocket emerge new species, genera, even orders, classes, and phyla. As Amber Dance writes in “Archaea Family Tree Blossoms, Thanks to Genomics” here, “The archaeal family tree has exploded in recent years, and the discoveries show no signs of slowing. . . . With these discoveries come insights into their unique and diverse biology, as well as their roles in the environment.” Add to those important implications the insight archaea give researchers trying to reconstruct the evolutionary relationships among the three domains of life.

This is an unsettled issue, even though there is general agreement that the intricate endosymbiosis that brought about eukaryotes happened. Some researchers, such as those Dance interviewed for her story, conclude that sequence data point to a freshly discovered, and more recently evolved, archaeal group, the Asgard superphylum, as the branch from which eukaryotes grew. But others, including Institut Pasteur scientists Patrick Forterre, Violette Da Cunha, and Morgan Gaia, contend that eukaryotes and archaea share a more recent ancestor than that shared by eukaryotes and bacteria. As they write in “Opinion: Archaea Is Our Evolutionary Sister, Not Mother,” here, “Archaea would be our sisters and bacteria our cousins.”

While this debate simmers and archaeal explorations bear fruit, I find myself, yet again, amazed not only by the complexity and history of life on Earth, but by the ability of one particular eukaryotic species to piece it all together. And to think, we humans could all conceivably trace our lineages back, through eons of evolution, to a couple of cells cooperating to make a go of it in a changing world. Those are some shared cultures I think all Homo sapiens can celebrate. 


Bob Grant
Editor-in-Chief

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.